Woman issues urgent warning after reta ‘nearly killed and ‘paralyzed’ her

During phased clinical trials of retatrutide, some patients lost around 5st

A TikTok creator has issued an urgent warning about the weight-loss drug retatrutide after claiming a dosing mistake left her seriously ill.

Lyndsey Jones (@Lyndz99) opened up about her frightening experience after previously sharing positive opinions about GLP-1 medications and retatrutide.

Despite suggesting that she was a supporter of the injections, Lyndsey said she felt it was important to share what happened to her.

“I think it's only fair that I come on here, tell you guys how it almost killed me,” she explained.

The TikToker revealed that her ordeal began after she took retatrutide earlier than she was supposed to, something she is now urging others never to do.

“Never take your reta before you're supposed to. I made that mistake, ended up in the ER twice, couldn't keep down any food or water,” she said.

Lyndsey described suffering extreme abdominal pain and frightening digestive symptoms, claiming her stomach began to feel as though it was becoming paralysed.

“I was in excruciating pain. My stomach was like starting to become paralyzed. It was terrifying.”

The experience became so severe that Lyndsey feared she might not survive.

“I seriously thought I was going to die at some point,” she admitted.

Her health struggles also had a dramatic impact on her weight and ability to eat.

According to Lyndsey, she went an entire week without being able to consume food, eventually dropping below 100 pounds, equivalent to approximately seven stone two pounds.

“I ended up weighing under 100 pounds. I couldn't eat for a whole entire week.”

Following the frightening ordeal, Lyndsey has decided to stop taking GLP-1 medications and is now receiving professional nutritional support as she focuses on maintaining her weight.

“Currently I am now seeing a nutritionist and I am not on GLP-1s, but I'm going to try to maintain the healthy way or the healthier way.”

Retatrutide is an experimental medication that’s being developed by Eli Lilly and Company – the world's largest pharmaceutical company and makers of Mounjaro.

Phased clinical trials have been taking place for both obesity and type 2 diabetes, with some remarkable results.

Often dubbed the 'Godzilla' of weight loss drugs, retatrutide targets three different hormone receptors to dramatically suppress appetite and increase fat burning, while current medications like Wegovy and Mounjaro only target one or two.

In a major trial involving more than 2,300 overweight adults, people taking the highest dose lost an average of 28.3 percent of their body weight, while some patients lost around 5st.

In Phase 2 trial data, the most commonly reported adverse effects included:

"Retatrutide is not yet available in the UK and has not been approved for use by any regulatory bodies – it is still undergoing clinical trials to assess its safety and effectiveness," Dr Clair Grainger, from Superdrug Online Doctor, said.

LADbible Group has contacted Eli Lilly and Company for comment.

Anish is a Journalist at LADbible Group and is a GG2 Young Journalist of the Year 2025. He has a Master's degree in Multimedia Journalism and a Bachelor's degree in International Business Management. Apart from that, his life revolves around the ‘Four F’s’ – family, friends, football and food. Email: [email protected]

These visuals, and the accompanying explanation, will surely put you off messing with the painful lumps filled with liquid

Tyler Riches had to beg for customers for cash to put petrol in his car after being kicked out of the family home

A ‘core memory unlocked’ for fans who owned one

The mum of two has since vowed to never travel abroad again